Tissue Regenix Group plc (AIM:TRX)
London · Delayed Price · Currency is GBP · Price in GBX 7.25
0.00 (0.00%)
Oct 22, 2025, 5:30 PM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 5.16 million as of November 3, 2025. Its market cap has decreased by -86.57% in one year.
Market Cap
5.16M
Enterprise Value
11.87M
Revenue
20.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.25
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 5.16M, a decrease of -87.40%. That is a compound annual growth rate of -12.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 5.16M | -87.92% |
| Dec 31, 2024 | 42.74M | 16.73% |
| Dec 29, 2023 | 36.61M | -7.68% |
| Dec 30, 2022 | 39.66M | 5.65% |
| Dec 31, 2021 | 37.54M | -0.93% |
| Dec 31, 2020 | 37.89M | 227.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.57B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |